Nuclea Biotechnologies Buys U.S. Biomarker Test Maker Oncogene Science for $5 Million

Just a few months after announcing several new partnerships and landing venture capital dollars, Nuclea Biotechnologies Inc. has snapped up Oncogene Science, an Cambridge, Mass.-based subsidiary of Wilex AG in Germany. The Pittsfield, Mass.-based company, with offices in Worcester, acquired all of the shares of Oncogene (Wilex Inc.) and will assume the assets of the company and take over repayment of a $2.5 million loan between the company and Wilex AG. Nuclea paid $5 million for the 11-person company and all of the employees will transition over to Nuclea, Spokesperson Greg D'Agostino said.

Help employers find you! Check out all the jobs and post your resume.